发布时间:2019-08-03 22:46 原文链接: RoleofMALinRhoMediatedActivationofSRF

Serum response factor (SRF) is a transcription factor, which binds to a serum response element (SRE) associated with a variety of genes including (i)immediate early genes such as c-fos, fosB, junB, egr-1 and -2, (ii)neuronal genes such as nurr1 and nur77, and (iii)muscle genes such as actins and myosins. By regulating expression of these genes, SRF controls cell growth and differentiation, neuronal transmission as well as muscle development and function. SRF can be activated by serum, lysophosphatidic acid (LPA), lipopolysaccharide (LPS), 12-O-tetradecanoylphorbol-13-acetate (TPA), cytokines, tumor necrosis factor-alpha (TNFalpha), agents that increase intracellular Ca2+, T-cell virus1 activator protein, hepatitis B virus activator proteins pX, activated oncogenes and protooncogenes and extracellular stimuli such as antioxidant and UV light. In serum-starved cells, MAL is predominantly cytoplasmic where it is sequestered by actin monomers. Upon serum stimulation, Rho becomes active and, through its interaction with ROCK and mDia1, causes an accumulation of F-actin and a commensurate decrease in the level of G-actin. As a consequence, MAL is no longer sequestered and is free to translocate to the nucleus where it associates with SRF and activates SRE-mediated gene expression.

Contributor: Kosi Gramatikoff, PhD

REFERENCES: Geneste, O., Copeland, J.W., and Treisman, R. (2002). J. Cell Biol. 157, 831?838 Gineitis, D., and Treisman, R. (2001). J. Biol. Chem. 276, 24531?24539 Hill, C.S., Wynne, J., and Treisman, R. (1995). Cell 81, 1159?1170. Miralles, F., Posern, G., Zaromytidou, A.I., and Treisman, R. (2003). Cell 113, 329?342. Montaner, S., Perona, R., Saniger, L., and Lacal, J.C. (1999). J. Biol.Chem. 274, 8506?8515. Natl. Acad. Sci. USA 99, 14855?14860. Nobes, C.D., and Hall, A. (1995). Biochem. Soc. Trans. 23, 456?459. Small, E., Krieg, P.A., and Olson, E.N. (2001). Cell 105, 851?862. Wang, D., Chang, P.S., Wang, Z., Sutherland, L., Richardson, J.A., online January 10, 2003. 10.1165/rcmb.2002-0206OC. Wang, D.Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J.A., Nordheim, A., and Olson, E.N. (2002). Proc. Natl. Acad. Sci. USA 99, 14855?14860.



相关文章

“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段

万物蓬勃的7月里迎来了2022年ANTOP奖的申报和评审工作。由岛津企业管理(中国)有限公司申报的“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段。奖项名称:3CoinONE全新体验......

青源峰达太赫兹在国际顶级期刊《TrendsinBiotechnology》发文

青岛青源峰达太赫兹科技有限公司研发团队在国际顶级期刊《TrendsinBiotechnology》(译名:《生物技术趋势》)在线发表题为“THzmedicalimaging:frominvitroto......

科学家将人工智能技术成功用于蛋白质复合物结构预测

蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......

发力癌症分子病理诊断,无锡臻和全资收购TissueofOrigin®

2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......

这3个杂志撤回中国学者249篇文章,包含上交、中山等名校

2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......

firstinclass胃癌一线疗法获FDA突破性疗法

安进宣布,美国FDA授予其在研firstinclass单抗bemarituzumab突破性疗法认定,与改良FOLFOX6化疗方案(亚叶酸钙、氟尿嘧啶和奥沙利铂)联用,一线治疗FGFR2b过表达和HER......

金属所三维伊辛模型精确解研究取得进展

2007年,中国科学院金属研究所研究员张志东在英国《哲学杂志》(PhilosophicalMagazine)上发表论文,提出两个猜想,并在猜想基础上推定出三维伊辛模型的精确解。被《哲学杂志》审稿人评价......

肿瘤治疗的强心剂,中国学者开发肿瘤治疗新策略

磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......

llumina宣布推出新型基因分型芯片|支持AllofUs研究计划

2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......

新一代蛋白结构预测技术

《NatureChemicalBiology》杂志在线版一篇文章介绍,伊利诺斯州立大学JohnA.Gerlt博士率领的研究小组研制出一种新途径,能够确定氨基酸序列已知的蛋白的结构和功能。这是首次利用计......